Abstract Library

#987 Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional MRI in Pancreatic Neuroendocrine Tumors and Comparison with 68Ga-DOTANOC PET/CT

Introduction: Pancreatic neuroendocrine tumors (pNETs) are often difficult to detect because of small size and have variable prognosis related to grading and staging.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Lanza F

Authors: Farchione A, Rufini V, Brizi M, Lanza F, Iacovazzo D,

Keywords: neuroendocrine tumors, MRI, DWI, PET,

#619 Diagnostic Accuracy of F-18-DOPA PET or PET/CT in Neuroendocrine Tumors: A Meta-Analysis

Introduction: A specific feature of NETs is amine precursor uptake and decarboxylation; this is the rationale for using PET with F-18-DOPA, a cathecholamine precursor, in diagnosis of NETs.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Treglia G

Authors: Muoio B, Treglia G, Rufini V,

Keywords: PET, PET/CT, F-18-DOPA, neuroendocrine tumors,

#484 Diagnostic Accuracy of Gallium-68 Somatostatin Receptor Positron Emission Tomography in Patients with Thoracic and Gastroenteropancreatic Neuroendocrine Tumors: A Meta-Analysis

Introduction: Gallium-68 somatostatin receptor (SMSR) positron emission tomography (PET) is a valuable diagnostic tool for patients with neuroendocrine tumors (NET). To date, a meta-analysis about the diagnostic accuracy of this functional imaging method is lacking.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Treglia G, Rufini V, Castaldi P, Muoio B, Giordano A,

Keywords: PET, Gallium-68, neuroendocrine tumors,